Results 21 to 30 of about 259 (175)

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response

open access: yesClinical and Translational Allergy, 2023
Background Despite advances in the treatment of chronic urticaria, in a significant percentage of the patients symptoms are not fully controlled with conventional approaches.
Ramón Gimeno   +7 more
doaj   +1 more source

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management

open access: yesWorld Allergy Organization Journal, 2021
This is Part 1 of an updated follow-up review of a World Allergy Organization (WAO) position paper published in 2012 on the diagnosis and treatment of urticaria and angioedema. Since 2012, there have been advances in the understanding of the pathogenesis
Mario Sánchez-Borges   +10 more
doaj   +1 more source

Chronic urticaria: new management options

open access: yesWorld Allergy Organization Journal, 2014
Chronic urticaria is defined as episodic or daily hives lasting for at least 6 weeks and impairs quality of life. Two main subtypes include chronic idiopathic (spontaneous) urticaria and inducible (physical) urticaria, but some patients have urticarial ...
Paul A. Greenberger
doaj   +1 more source

Advances in Understanding and Managing Chronic Urticaria [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
There have been recent advances in the classification and management of chronic urticaria. The new term chronic spontaneous urticaria (CSU) has replaced chronic idiopathic urticaria and chronic autoimmune urticaria.
Yasmin Moolani   +2 more
doaj   +1 more source

A Disease Marker for Aspirin-Induced Chronic Urticaria [PDF]

open access: yesInternational Journal of Molecular Sciences, 2014
There are currently no diagnostic methods in vitro for aspirin-induced chronic urticaria (AICU) except for the provocation test in vivo. To identify disease markers for AICU, we investigated the single nucleotide polymorphism (SNP) of the promoter loci of high-affinity IgE receptor (FcεRIα) and CD203c expression level in Chinese patients with AICU.
Hsieh, Chia-Wei   +3 more
openaire   +2 more sources

CHRONIC AUTOIMMUNE URTICARIA IN CHILDREN

open access: yesSlovenska pediatrija, 2021
Urticaria is a common disease in childhood, characterised by the appearance of a transient itchy nettle rash on the skin, which may be accompanied by angioedema.
Lana Stergar   +2 more
doaj   +1 more source

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases

open access: yesAllergy, Asthma & Clinical Immunology, 2023
Background While both the AAAAI/ACAAI and the EAACI/GA2LEN/EuroGuiDerm/APAAACI guidelines recommend starting cyclosporine for patients with chronic urticaria who have had an inadequate response to omalizumab, many clinicians are hesitant to initiate ...
Anthony F. LaCava, Olajumoke O. Fadugba
doaj   +1 more source

Urticaria and angioedema

open access: yesAllergy, Asthma & Clinical Immunology, 2018
Urticaria (hives) is a common disorder that often presents with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic.
Amin Kanani   +2 more
doaj   +1 more source

Quality of Life Assessment in Patients with Idiopathic and Inducible Chronic Urticaria

open access: yesPakistan Armed Forces Medical Journal
Objective: To determine impact on quality of life (QoL) in patients of Chronic Urticaria (CU) and to compare it between Idiopathic and Inducible Chronic Urticaria. Study Design: Cross-sectional study.
Sara Sarwar   +5 more
doaj   +1 more source

Long term treatment with omalizumab in adolescent with refractory solar urticaria

open access: yesItalian Journal of Pediatrics, 2021
Background Solar urticaria represents an uncomfortable form of chronic inducible urticaria. First and second-line treatments are ineffective in some patients, leading to an impairment in their quality of life.
Mauro Iannelli   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy